Primary carcinoma of the vagina is a radiotherapeutic problem which deserves a good prognosis. Because it is an infrequent disease (1 to 1.5 per cent of gynecologic cancer), there are few radiation therapists or surgeons who have had extensive experience in its management. Between 1919 and 1955, 174 patients with primary carcinoma of the vagina were examined at the Roswell Park Memorial Institute. Thirteen of these are not included in this report because 7 received surgery only (average survival of nineteen months, extremes one and a half and forty-three months), 5 were treated elsewhere, and 1 was given irradiation to the inguinal metastases only (survived fourteen months). This report includes, however, the 132 patients with carcinoma reported by one of us (W.T.M.) in 1957. All the cases in this report are squamous-cell carcinomas except for 1 adenocarcinoma. This was identified as a primary vaginal lesion only after a careful clinical search revealed no other primary site. The average age of the 161 irradiated patients was 57.4 years. Four were under forty years of age and 27 over seventy. The youngest patient was thirty-four. Although carcinoma may originate in any segment of the vagina, the most common site of origin was the posterior wall (approximately 45 per cent of this series). Symptoms were usually those of ulceration; namely, watery discharge and/or bleeding of an average duration of seven months. Ten out of the 161 irradiated patients were asymptomatic at the time the neoplasm was diagnosed. Clinically, the cases have been classified as follows: Stage I (90 cases): The lesion is limited to the vagina or immediate paravaginal tissue. Peripherally, it may involve the face of the cervix but not the mucosquamous junction. Area of lesion is not a factor. Stage II (57 cases): The lesion has extended beyond the immediate paravaginal tissue, e.g., vulva, parametrium, regional lymph nodes, mucous membrane of the urethra, bladder, or rectum, and distant metastases. Stage III (14 cases): The lesion has received definitive treatment (surgery or irradiation) before admission to and irradiation at the Roswell Park Memorial Institute, Buffalo, N. Y. Treatment Many different radiotherapeutic technics have been used in the treatment of the patients reported in this series and have been described by one of us (W.T.M.) in previous publications (1, 2). It is important to state that most patients are best treated by a combination of teleradiation and surface or interstitial radioactive sources. Only the small accessible lesion can be managed confidently by an interstitial implant or surface applicator alone. The technic must be individualized to meet the particular clinical situation. End Results Table I shows the number of five-year survivals without evidence of carcinoma. Tables II and III illustrate how the successful cases in the 1940–1955 series were managed. Table IV lists the complications observed after a post-treatment period of at least six months. Conclusion Primary carcinoma of the vagina is a radiotherapeutic problem that has resulted in a 59 per cent five-year “cure” rate in those 27 patients with clinical Stage I involvement irradiated since 1940, at which time x-ray qualities of 2.5 mm. to 9.0 mm. Cu h.v.l. became available.